Vitamins That Remove Plaque From Arteries: What the Evidence Actually Shows

Vitamins that remove plaque from arteries — the claim appears regularly in supplement marketing. The honest clinical answer is more nuanced: no vitamin dissolves or removes existing plaque. But several vitamins and nutrients have robust evidence for slowing plaque progression, reducing the oxidative and inflammatory processes that drive atherosclerosis, and in some cases directly supporting arterial wall health. This guide covers what the evidence actually shows, at what doses, and which patients benefit most.

Vitamins and Nutrients With Evidence for Arterial Health

1. Vitamin K2 (MK-7 Form) — The Artery Calcification Vitamin

Vitamin K2 is the most clinically important vitamin for arterial health, though it remains poorly understood outside integrative medicine. Its primary cardiovascular mechanism is activation of Matrix Gla Protein (MGP) — a protein that prevents calcium from depositing in arterial walls. When K2 levels are insufficient, MGP remains inactive and calcium migrates into soft tissues including arteries, driving arterial stiffening and calcification (the primary component of “hardening of the arteries”).

The Rotterdam Study — a landmark Dutch population study — found that participants with the highest dietary vitamin K2 intake had a 52% lower risk of severe aortic calcification and 57% lower cardiovascular mortality compared to those with the lowest intake. The MK-7 form of vitamin K2 has the longest half-life (72 hours versus 1 hour for MK-4), providing more sustained MGP activation. Standard dose: 90–180 mcg daily of MK-7. Patients on warfarin must consult their physician before supplementing with any form of vitamin K.

2. Vitamin D3 — Vascular Tone and Inflammation

Vitamin D receptors are expressed throughout the cardiovascular system — including in endothelial cells, vascular smooth muscle, and cardiac myocytes. Deficiency (defined as serum 25-OH-D below 20 ng/mL, which affects over 40% of US adults) is associated with hypertension, increased arterial stiffness, elevated inflammatory markers, and higher cardiovascular event rates. Vitamin D reduces renin production (lowering blood pressure), modulates macrophage function (reducing plaque inflammation), and improves endothelial function. Standard replacement dose: 2,000–5,000 IU daily of D3, ideally with K2 (D3 promotes calcium absorption, K2 directs it to bones rather than arteries — the two work synergistically). Dose should be guided by 25-OH-D blood levels.

3. Magnesium — The Overlooked Vascular Mineral

Magnesium is not technically a vitamin but is the most commonly deficient micronutrient in patients with cardiovascular disease, and its vascular effects are profound. Magnesium acts as a natural calcium channel blocker — it relaxes vascular smooth muscle, reducing blood pressure and arterial stiffness. Low intracellular magnesium is associated with increased arterial calcification, endothelial dysfunction, platelet hyperactivity, and arrhythmia susceptibility. Standard serum magnesium testing misses intracellular deficiency — Dr. Druz uses RBC magnesium for accurate assessment. Standard supplemental dose: 200–400 mg daily of magnesium glycinate or malate (better tolerated than magnesium oxide).

4. Omega-3 Fatty Acids (EPA and DHA)

Omega-3 fatty acids are the most extensively studied cardiovascular supplements with the strongest outcomes data. EPA and DHA reduce triglycerides by 20–50% at therapeutic doses, lower inflammatory markers (IL-6, hsCRP), reduce platelet aggregation, and improve endothelial function. The REDUCE-IT trial demonstrated that high-dose EPA (4 grams daily) reduced major cardiovascular events by 25% in high-risk statin-treated patients with elevated triglycerides. Therapeutic cardiovascular dose: 2–4 grams daily of combined EPA+DHA. Quality matters — choose products with third-party testing for oxidation and heavy metals.

5. Coenzyme Q10 (CoQ10) — Mitochondrial Support and LDL Protection

CoQ10 is an endogenous antioxidant critical for mitochondrial energy production in heart muscle and for protecting LDL from oxidation — the initiating step in atherosclerotic plaque formation. Statins deplete CoQ10 by inhibiting the mevalonate pathway, and many of the muscle symptoms attributed to statins are believed to be at least partially driven by CoQ10 depletion. Clinical trials show CoQ10 reduces systolic blood pressure by approximately 11 mmHg and diastolic by approximately 7 mmHg. Standard dose: 100–400 mg daily; the ubiquinol form has superior absorption, particularly in patients over 50.

6. Vitamin C — Endothelial Protection and Collagen Synthesis

Vitamin C is the primary water-soluble antioxidant in plasma and plays a specific role in cardiovascular health by regenerating oxidized vitamin E, supporting endothelial nitric oxide production, and reducing LDL oxidation. It is also essential for collagen synthesis — the structural protein that maintains arterial wall integrity. Epidemiological studies consistently show inverse associations between vitamin C status and cardiovascular disease. Standard cardiovascular dose: 500–1,000 mg daily of ascorbic acid or buffered vitamin C. Unlike fat-soluble vitamins, excess vitamin C is excreted and toxicity is rare.

When to See a Doctor About Vitamins and Arterial Health

The Integrative Cardiology Approach

At Holistic Heart Centers, vitamin and nutrient optimization is part of a comprehensive cardiovascular protocol — not a generic supplement stack. Dr. Druz assesses each patient’s deficiency profile, arterial health status (including CAC scoring), and medication list before recommending specific nutrients at specific doses. The D3+K2 combination, magnesium, and omega-3s are the starting point for most patients — but the precise protocol depends on what the testing reveals.

Want to know which vitamins are right for your arterial health

A Step 1 Explore visit with Dr. Druz includes comprehensive micronutrient assessment alongside advanced lipid and arterial imaging.

References

1. Geleijnse JM, et al. Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease. J Nutr. 2004;134(11):3100-3105.
2. Bhatt DL, et al. Cardiovascular Risk Reduction with Icosapentaenoic Acid (REDUCE-IT). N Engl J Med. 2019;380(1):11-22.
3. Rosenfeldt FL, et al. Coenzyme Q10 in the Treatment of Hypertension. J Hum Hypertens. 2007;21(4):297-306.
4. Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357(3):266-281.